GC
RGDX

Guggenheim Capital’s RESPONSE GENETICS, INC COMMON SHS (DELAWARE) RGDX Stock Holding History

Guggenheim Capital’s Portfolio RGDX Stock Details RGDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-11,616
Closed -$11K – 3254
2014
Q2 		$11K Sell
11,616
-1,162
-9% -$1.22K ﹤0.01% 3186
2014
Q1 		$15K Buy
+12,778
New +$17.8K ﹤0.01% 3249

Other funds holding RGDX

BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
LPU
Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
AWMDMG
Austin W. Marxe & David M. Greenhouse New York $733M AUM 21.72% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Guggenheim Capital's RGDX Position: Q3 2014 in Review

Guggenheim Capital sold out of RESPONSE GENETICS, INC COMMON SHS (DELAWARE) (RGDX) in Q3 2014, closing a stake of 11,616 shares — an estimated $11K sold.

Guggenheim Capital first reported a position in RGDX in Q1 2014 and held it in 2 quarters. The position peaked at $15K in Q1 2014. 18 funds tracked by Wall St. Rank hold RGDX as of Q3 2014.

  • Guggenheim Capital reported no remaining RESPONSE GENETICS, INC COMMON SHS (DELAWARE) position as of Q3 2014 after selling out during the quarter.
  • Guggenheim Capital sold 11,616 RESPONSE GENETICS, INC COMMON SHS (DELAWARE) shares in Q3 2014, an estimated $11K.
  • Guggenheim Capital first reported a position in RESPONSE GENETICS, INC COMMON SHS (DELAWARE) in Q1 2014 and held it in 2 quarters.
  • Guggenheim Capital's RESPONSE GENETICS, INC COMMON SHS (DELAWARE) position peaked at $15K in Q1 2014.
  • 18 funds tracked by Wall St. Rank held RESPONSE GENETICS, INC COMMON SHS (DELAWARE) as of Q3 2014.

Based on Guggenheim Capital's 13F filing for Q3 2014, filed 14 Nov 2014.